Cookie Img
Home » Products » Pharmaceutical Injection » Humira Pen Adalimumab

Humira Pen Adalimumab

Humira Pen Adalimumab
Humira Pen Adalimumab
Product Code : AP/0001
Brand Name : Adalimumab
Product Specifications
  • Drug Type
  • Injection
  • Ingredients
  • Humira
  • Suitable For
  • Adults
Product Description
Uses
HUMIRA is a prescription medication used for:
  • To lessen the signs and symptoms of:
  • Moderate to serious rheumatoid arthritis (RA) in people over 18 years. It can be used without help, with methotrexate, or with specific other medications. It may stop further injury to bones and joints and can help your capability to do daily activities.
  • Moderate to serious polyarticular juvenile idiopathic arthritis in kids 2 years of age and elder.
  • It can be taken alone, with methotrexate, or with specific other medicines.
  • Psoriatic arthritis (PsA) in people above 18 years. It can be taken alone or with specific other medications. It may prevent additional damage to bones and joints and can help your capability to do daily activities.
  • Ankylosing spondylitis in adults.
  • Moderate to serious Crohn's disease (CD) and to attain and uphold clinical remission in people above 18 years, who have not reacted well to certain other medications. It is also taken for reducing signs and indications and to attain clinical reduction in adults who have lost reaction to or are incapable to endure infliximab.
  • Moderate to serious Crohn's disease (CD) and to attain and uphold clinical reduction in kids 6 years of age and older when specific other cures have not functioned well enough.
  • Moderate to serious hidradenitis suppurativa (HS) in adults.
  • In people above 18 years, to aid get moderate to serious ulcerative colitis (UC) below control and keep it under regulation (sustain remission) while few other medications have not functioned well sufficient.
  • To treat moderate to serious serious plaque psoriasis (Ps) in people above 18 years who are organized for phototherapy or systemic therapy, and are below the care of a medical practitioner who will choose if additional systemic therapies are less suitable.
  • To treat non-infectious intermediate, panuveitisand posterior (back of the eye) (all parts of the eye) (UV) in people above 18.
Note*:
Serious infections have occurred in persons taking HUMIRA. These grave infections include tuberculosis (TB) and infections resulted by fungi, viruses, or bacteria that have grown throughout the body. Few people have died from such infections. It may upsurge the chance of receiving lymphoma, comprising a rare sort, or other cancers. It can cause severe side effects like hepatitis B infection in carters of the virus, nervous system problems, allergic reactions, heart failure, blood problems, specific immune reactions comprising a lupus-like syndrome, new or worsening psoriasis and liver problems.
Trade Information
  • Payment Terms
  • Cash Advance (CA), Delivery Point (DP), Western Union
  • Sample Available
  • Yes
  • Main Export Market(s)
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • Main Domestic Market
  • All India

AMBICA PHARMA

Contact Us

( *represents compulsory fields )

Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



AMBICA PHARMA All Rights Reserved.